Endocrine gland abnormalities in thalassemia major: A brief review

Journal of Pediatric Endocrinology and Metabolism

Volumn 16, Issue 7, 2003, Pages 957-964

  Mohammadian, Sakineh ^a,b   Bazrafshan, Hamid Reza ^a,b   Sadeghi Nejad, Ab ^a,b  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Beta thalassemia; Delayed puberty; Diabetes mellitus; Endocrine failure; Endocrine gland; Iron toxicity; Short stature; Thalassemia major

Indexed keywords

DEFEROXAMINE; GONADORELIN; HEMOGLOBIN; IRON; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADRENAL INSUFFICIENCY; BETA THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; DIABETES MELLITUS; ENDOCRINE DISEASE; GEOGRAPHY; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HUMAN; HYPOGONADISM; HYPOPARATHYROIDISM; HYPOTHYROIDISM; IRON CHELATION; IRON OVERLOAD; LIFE EXPECTANCY; MORBIDITY; MORTALITY; POPULATION MIGRATION; POPULATION RESEARCH; QUALITY OF LIFE; REVIEW; THALASSEMIA MAJOR;

ADRENAL INSUFFICIENCY; BETA-THALASSEMIA; BODY HEIGHT; CHILD; DIABETES MELLITUS; ENDOCRINE SYSTEM DISEASES; HUMANS; HYPOGONADISM; HYPOPARATHYROIDISM; HYPOTHYROIDISM;

EID: 0141960433     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Olivieri NF. Medical progress: the beta-thalassemias. N Engl J Med 1999; 341: 99-109.
2. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR. Survival in medically treated patients with homozygous β thalassemia. N Eng J Med 1994; 331: 574-578.
3. Rund D, Rachmilewitz E. Thalassemia major 1995: older patients, new therapy. Blood Rev 1995; 9: 25-32.
4. Flynn DM, Fairney A, Jackson D, Clayton BE. Hormonal changes in thalassemia major. Arch Dis Child 1976; 51: 828-836.
5. Aydinok Y, Darcan S, Polat A, Kavakli K, Nigli G, Coker M, Kantar M, Cetingul M. Endocrine complications in patients with beta-thalassemia major. J Trop Pediatr 2002; 48: 50-54.
6. Yesilipek MA, Bircan I, Oygur N. Growth and sexual maturation in children with thalassemia major. Haematologica 1993; 78: 30-33.
7. Vullo C, De Sanctis V, katz M, Wonke B, Hoffbrand AV, Bagni B, Torresani B, Tolis G, Rosiero M, DiPalma A. Endocrine abnormalities in thalassemia. Ann NY Acad Sci 1990; 612: 293-310.
8. Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol 2000; 13: 651-656.
9. Saka N, Sukur M, Bundak R, Anak S, Neyzi O, Gedikoglu G. Growth and puberty in thalassemia major. J Pediatr Endocrinol Metab 1995; 8: 181-186.
10. Grundy RG, Woods KA, Savage MO, Evans JP. Relationship of endocrinopathy to iron chelation status in young patients with thalassemia major. Arch Dis Child 1994; 71: 128-132.
11. Propper RD, Cooper B, Rufo RR, Nienhuis AW, Anderson WF, Bunn HF, Rosenthal A, Nathan DG. Continuous subcutaneous administration of deferoxamine in patients with iron overload. N Engl J Med 1977; 297: 418-423.
12. Roth C, Pekrun A, Bartz M, Jarry H, Eber S, Lakomek M, Schroter W. Short stature and failure of pubertal development in thalassemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion. Eur J Pediatr 1997; 156: 777-783.
13. Malizia R, Scorsone A, D'Angelo P, Lo Pinto P, Pitrolo L, Giordano C. Zinc deficiency and cell-mediated and humoral autoimmunity of insulin-dependent diabetes in thalassemic subjects. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3): 981-984.
14. Hotz C, Brown KH. Identifying populations at risk of zinc deficiency: the use of supplementation trials. Nutr Rev 2001; 59: 80-84.
15. Ninh NX, Thissen JP, Collette L, Gerard G, Khoi HH, Ketelslegers JM. Zinc supplementation increases growth and circulating insulin-like growth factor-1 (IGF-1) in growth-retarded Vietnamese children. Am J Clin Nutr 1996; 63: 514-519.
16. Masala A, Meloni T, Gallisai D, Alagna S, Rovasio PP, Rassu S, Melia AF. Endocrine functioning in multitransfused prepubertal patients with homozygous beta-thalassemia. J Clin Endocrinol Metab 1984; 58: 667-670.
17. Attie KM, Carlsson LM, Rundle AC, Sherman BM. Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study. J Pediatr 1995; 127: 244-250.
18. Soliman AT, El Banna N, Abdel Fattah M, El Zalabani MM, Ansari BM. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Metabolism 1998; 47: 541-548.
19. Chrysis DC, Alexandrides TK, Koromantzou E, Georgopoulos N, Vassilakos P, Kiess W, Kratsch B, Beratis NG, Spiliotis BE. Novel application of IGF-1 and IGF-BP3 generation test in the diagnosis of growth hormone axis disturbances in children with beta-thalassemia. Clin Endocrinol 2001; 54: 253-259.
20. Soliman AT, elZalabany MM, Mazloum Y, Bedair SM, Ragab MS, Rogol AD, Ansari BM. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor 1 (IGF-1) concentration in patients with beta thalassemia and delayed growth. J Trop Pediatr 1999; 45: 327-337.
21. Katzos G, Harsoulis F, Papadopoulou M, Athanasiou M, Sava K. Circadian growth hormone secretion in short multitransfused prepubertal children with thalassemia major. Eur J Pediatr 1995; 154: 445-449.
22. Chatterjee R, Katz M, Cox T, Bantock H. Evaluation of growth hormone in thalassemic boys with failed puberty: spontaneous versus provocative test. Eur J Pediatr 1993; 152: 721-726.
23. Saenger P, Schwartz E, Markenson AL, Graziano JH, Levine LS, New MI, Hilgarter MW. Depressed serum somatomedin activity in beta-thalassemias. J Pediatr 1980; 96: 214-218.
24. De Sanctis V, Galimberti M, Lucarelli G, Angelucci E, Ughi M, Baronciani D, Polchi P, Giardini C, Vullo C, Bagni B. Gonadal function in long term survivors with β thalassemia major following bone marrow transplantation. Bone Marrow Transplant 1993; 12 (Suppl 1): 104-109.
25. Chatterjee R, Katz M, Cox TF. Prospective study of the hypothalamic-pituitary axis in thalassemic patients who developed secondary amenorrhea. Clin Endocrinol 1993; 39: 287-296.
26. Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland FJ. Effects of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major. N Engl J Med 1990; 323: 713-719.
27. Italian Working Group on Endocrine Complications in Non-endocrine Disease. Multicenter study of prevalence of endocrine complication in thalassemia major. Clin Endocrinol 1995; 42: 581-586.
28. De Sanctis V, Vullo C, Katz M, Wonke B, Hoffbrand AV, Bagni B. Hypothalamic-pituitary-gonadal axis in thalassemia patients with secondary amenorrhea. Obstet Gynecol 1988; 72: 643-647.
29. Rasekhi ALR, Bagheri MH, Sadegholvaad AS, Omrani GH, Rasekhi AHR. Correlation between pituitary MRI and hypogonadotropic hypogonadism in β thalassemia. Iran J Med Sci 2000; 25: 21-24.
30. Valenti S, Giusti M, McGuinness D, Guido R, Mori PG, Giordano G, Dahl KD. Delayed puberty in males with beta-thalassemia major: pulsatile gonadotropin-releasing hormone administration induces changes in gonadotropin isoform profiles and an increase in sex steroids. Eur J Endocrinol 1995; 133: 48-56.
31. McIntosh N. Endocrinopathy in thalassemia major. Arch Dis Child 1976; 51: 195-201.
32. De Virgiliis S, Congia M, Frau F, Argiolu F, Diana G, Cucca F, Varsi A, Sanna G, Podda G, Fodde M, Franco'Pirastu G, Cao A. Deferoxamine-induced growth retardation in patients with thalassemia major. J Pediatr 1988; 113: 661-669.
33. Rodda CP, Reid ED, Johnson S, Doery J, Matthews R, Bowden DK. Short stature in homozygous beta-thalassemia is due to disproportionate truncal shortening. Clin Endocrinol 1995; 42: 587-592.
34. De Sanctis V, Pinamonti A, Di Palma A. Growth and development in thalassemia major patients with severe bone lesion due to desferoxamine. Eur J Pediatr 1996; 155: 368-372.
35. Mordel N, Birkenfield A, Goldfarb AN, Rachmilewitz AE. Successful full-term pregnancy in homozygous beta thalassemia major: case report and review of the literature. Obstet Gynecol 1989; 73: 837-840.
36. Savona-Ventura C, Bonello F. Beta-thalassemia syndromes and pregnancy. Obstet Gynecol Surv 1994; 49: 129-137.
37. Jensen CE, Tuck SM, Wonke B. Fertility in beta thalassemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature. Br J Obstet Gynaecol 1995; 102: 625-629.
38. Danesi L, Scacchi M, Miragoli AM, Pincelli AI, Dubini A, Maiolo AT, Cavagnini F, Polli EE. Induction of follicle maturation and ovulation by gonadotropin administration in women with beta-thalassemia. Eur J Endocrinol 1994; 131: 602-606.
39. Aessopos A, Karabatsos F, Farmakis D, Katsantoni A, Hatziliami A, Youssef J, Karagiorga M. Pregnancy in patients with well-treated beta-thalassemia: outcome for mothers and newborn infants. Am J Obstet Gynecol 1999; 180: 360-365.
40. Daskalakis GJ, Papageorgiou IS, Antsaklis AJ, Michalas SK. Pregnancy and homozygous beta thalassaemia major. Br J Obstet Gynaecol 1998; 105: 1028-1032.
41. Gabriele OF. Hypoparathyroidism associated with thalassemia. South Med J 1971; 64: 115-116.
42. Chern JP, Lin KH. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Pediatr Hematol Oncol 2002; 24: 291-293.
43. Zafeiriou DI, Athanasiou M, Katzos G, Economou M, Kontopoulos E. Hypoparathyroidism and intracranial calcifications in beta-thalassemia major. J Pediatr 2001; 138: 411.
44. De Sanctis V, Vullo C, Bagni B, Chiccoli L. Hypoparathyroidism in beta-thalassemia major: clinical and laboratory observations in 24 patients. Acta Haematol 1992; 88: 105-108.
45. Alagna S, Masala A, Gallisai D, Ginnani A, Burrai C, Pinna A, Rassu S, Rovasio P, Devilla L. Parathyroid function and bone metabolism in children with beta-thalassemia major: effects of sex steroid treatment. Eur J Med 1992; 1: 153-157.
46. Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adults with beta-thalassemia major and intermedia. Br J Haematol 2001; 111: 902-907.
47. Filosa A, Di Maio S, Vocca S, Saviano A, Esposito G, Pagono L. Longitudinal monitoring of bone mineral density in thalassemic patients: genetic structure and osteoporosis. Acta Paediatr 1997; 86: 342-346.
48. Voskaridou E, Kyrtsonis MC, Terpos E, Skordili M, Theodoropoulos I, Bergele A, Diamanti E, Kalovidouris A, Loutradi A, Loukopoulos D. Bone resorption is increased in young adults with thalassemia major. Br J Haematol 2001; 112: 36-41.
49. Lasco A, Morabito N, Gaudio A, Buemi M, Wasniewska M, Frisina N. Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major. Osteoporosis Int 2001; 12: 570-575.
50. Molyvda-Athanasopoulou E, Sioundas A, Karatzas N, Aggellaki M, Pazaitou K, Vainas I. Bone mineral density of patients with thalassemia major: four-year follow-up. Calcified Tissue Int 1999; 64: 481-484.
51. Perrotta S, Cappellini MD, Bertoldo F, Servedio V, Iolascon G, D'Agruma L, Gasparini P, Siciliani MC, Iolascon A. Osteoporosis in beta-thalassemia major patients: analysis of the genetic background. Br J Haematol 2000; 111: 461-466.
52. Chow LH, Frei JV, Hodsman AB, Valberg LS. Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status. Gastroenterology 1985; 88: 865-869.
53. Olivieri NF, Koren G, Harris J, Khattak S, Freedman MH, Templeton DM, Bailey JD, Reilly BJ. Growth failure and bony changes induced by deferoxamine. Am J Pediatr Hematol Oncol 1992; 14: 48-56.
54. Chern JP, Lin KH, Lu MY, Lin DT, Lin KS, Chen JD, Fu CC. Abnormal glucose tolerance in transfusion dependent beta-thalassemic patients. Diabetes Care 2001; 24: 850-854.
55. Cavallo-Perin P, Pacini G, Cerutti F, Bessone A, Condo C, Sacchetti L, Piga A, Pagano G. Insulin resistance and hyperinsulinemia in homozygous beta-thalassemia. Metabolism 1995; 44: 281-286.
56. Costin G, Kogut MD, Hyman C, Ortega JA. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major. Diabetes 1977; 26: 230-240.
57. Arrigo T, Crisafulli G, Meo A, Sturiale M, Lombardo F, Miceli M, Cucinotta D, De Luca F. Glucose tolerance, insulin secretion and peripheral sensitivity in thalassemia major. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3): 863-866.
58. el-Hazmi MA, al-Swailem A, al-Fawaz I, Warsey AS, al-Swailem A. Diabetes mellitus in children suffering from beta-thalassemia. J Trop Pediatr 1994; 40: 261-266.
59. Labropoulou-Karatza C, Goritsas C, Fragopanagou H, Repandi M, Matsouka P, Alexandrides T. High prevalence of diabetes mellitus among adult beta-thalassemic patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 1999; 11: 1033-1036.
60. Dmochowski K, Finegood DT, Francombe W, Tyler B, Zinman B. Factors determining glucose tolerance in patients with thalassemia major. J Clin Endocrinol Metab 1993; 77: 478-483.
61. De Sanctis V, Zurlo MG, Senesi E, Boffa C, Cavallo L, Di Gregorio F. Insulin-dependent diabetes in thalassemia. Arch Dis Child 1988; 63: 58-62.
62. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by transfusion. N Engl J Med 1988; 318: 809-814.
63. Jones TW, Boulware SD, Caprio S, Merkel P, Amiel SA, Pearson HA, Sherwin RS, Tamborlane WV. Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major. Pediatr Res 1993; 33: 497-500.
64. Ladis V, Theodorides C, Palamidou F, Frissiras S, Berdousi H, Kattamis C. Glucose disturbances and regulation with glibenclamide in thalassemia. J Pediatr Endocrinol Metab 1998; 11 (Suppl 3): 871-878.
65. Madeddu G, Dore A, Marongiu A, Langer-Costanzi M. Growth retardation, skeletal maturation and thyroid function in children with homozygous beta-thalassemia. Clin Endocrinol 1978; 8: 359-365.
66. Zervas A, Katopodi A, Protonotariou A, Livadas S, Karagiorga M, Politis C, Tolis G. Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyroid 2002; 12: 151-154.
67. Sabato AR, de Sanctis V, Atti G, Capra L, Bagni B, Vullo C. Primary hypothyroidism and the low T3 syndrome in thalassemia major. Arch Dis Child 1983; 58: 120-127.